Minerva Neurosciences, Inc. Convertible Notes Payable, Current
Minerva Neurosciences, Inc. (NERV) had Convertible Notes Payable, Current of $2.01 million as of 2014-06-30, per its 10-Q filed 2014-08-07.
Discontinued › Balance Sheet › Liabilities › Liabilities, Current › Debt, Current › Long-Term Debt, Current Maturities › Notes and Loans Payable, Current › Notes Payable, Current
us-gaap:ConvertibleNotesPayableCurrent · last filed 2015-03-26
- 2014-06-30: Convertible Notes Payable, Current $2.01M.
- 2013-12-31: Convertible Notes Payable, Current $58.27K.
| Period end | Convertible Notes Payable, Current |
|---|---|
| 2014-06-30 | $2.01M 10-Q · filed 2014-08-07 |
| 2013-12-31 | $58.27K 10-K · filed 2015-03-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Tonix Pharmaceuticals Holding Corp. (TNXP) | United States | $0.166B | -1.34 |
| ADC Therapeutics SA (ADCT) | $0.163B | -1.39 | |
| LIFECORE BIOMEDICAL, INC. DE (LFCR) | United States | $0.163B | -8.50 |
| Organogenesis Holdings Inc. (ORGO) | United States | $0.182B | -3.70 |
| Annexon, Inc. (ANNX) | United States | $0.147B | -4.22 |
| AN2 Therapeutics, Inc. (ANTX) | United States | $0.185B | -4.84 |
| PepGen Inc. (PEPG) | United States | $0.186B | -1.73 |
| Corbus Pharmaceuticals Holdings, Inc. (CRBP) | United States | $0.144B | -1.72 |
| ALX ONCOLOGY HOLDINGS INC (ALXO) | United States | $0.187B | -3.52 |
| Fortress Biotech, Inc. (FBIO) | United States | $0.188B | 0.91 |